Peripartum Cardiomyopathy in the Bromocriptine Era: A Systematic Review and Meta-analysis of Targeted Prolactin Blockade, Patient Selection, and Perinatal Care Pathways
Annals of Clinical Cardiology · 2026-01 · 8 (1) · 4-17
DOI: 10.4103/accj.accj_22_25 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Annals of Clinical Cardiology, online erschienen am 08.05.2026. Verfasst von Efendi Lukas und 19 weiteren Autor:innen. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Peripartum cardiomyopathy (PPCM) remains a leading cause of maternal heart failure worldwide, yet its management has entered a transformative “bromocriptine era” with renewed mechanistic insight and emerging multicenter data. This systematic review and meta-analysis reappraises the pathobiology, therapeutic strategies, and patient selection criteria for targeted prolactin blockade in PPCM. Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 standards, a comprehensive search of PubMed, Embase, and Cochrane Library (last updated May 2025) identified 1896 records, from which 35 studies met inclusion criteria encompassing randomized trials, registries, observational cohorts, and mechanistic investigations. Data were extracted independently by two reviewers using validated bias assessment tools (AMSTAR-2, ROBINS-I/E, RoB-2, and SANRA). Outcomes included left ventricular ejection fraction (LVEF) recovery, mortality, and adverse events. Across pooled analyses, bromocriptine use was consistently associated with improved LVEF recovery (mean Δ +9%–12%) and a 35%–45% relative reduction in mortality compared with standard therapy alone, without increased thromboembolic risk when paired with prophylactic anticoagulation. Mechanistic studies confirmed suppression of the pathogenic 16-kDa prolactin fragment and oxidative injury. Subgroup findings highlighted the importance of early initiation (≤72 h postpartum), therapy duration ≥6 weeks, and integrated lactation and thromboprophylaxis planning. The present synthesis provides the first unified evaluation of targeted prolactin blockade within contemporary cardio-obstetric care. Beyond validating bromocriptine’s efficacy and safety, it establishes a refined perinatal care pathway that integrates mechanistic rationale, maternal–fetal safety, and policy-level recommendations. These findings call for harmonized clinical protocols, expanded registries, and global equity in access to advanced PPCM therapy.
Zitieren
APA
Lukas, E., Andonotopo, W., Pramono, M. B. A., Dewantiningrum, J., Prabowo, W., Bachnas, M. A., Sanjaya, I. N. H., Wiradnyana, A. A. G. P., Kusuma, A. A. N. J., Gumilar, K. E., Darmawan, E., Akbar, M. I. A., Aldiansyah, D., Suryawan, A., Putra, R. A., Anwar, A. D., Nugraha, L. A. K., Andanaputra, W. E. K., Dharma, W. A. K., & Stanojevic, M. (2026). Peripartum Cardiomyopathy in the Bromocriptine Era: A Systematic Review and Meta-analysis of Targeted Prolactin Blockade, Patient Selection, and Perinatal Care Pathways. Annals of Clinical Cardiology, 8(1), 4-17. https://doi.org/10.4103/accj.accj_22_25
Vancouver
Lukas E, Andonotopo W, Pramono MBA, Dewantiningrum J, Prabowo W, Bachnas MA, et al. Peripartum Cardiomyopathy in the Bromocriptine Era: A Systematic Review and Meta-analysis of Targeted Prolactin Blockade, Patient Selection, and Perinatal Care Pathways. Annals of Clinical Cardiology. 2026;8(1):4-17. doi:10.4103/accj.accj_22_25
BibTeX
@article{Lukas2026,
author = {Lukas, Efendi and Andonotopo, Wiku and Pramono, Mochammad Besari Adi and Dewantiningrum, Julian and Prabowo, Wisnu and Bachnas, Muhammad Adrianes and Sanjaya, I Nyoman Hariyasa and Wiradnyana, Anak Agung Gede Putra and Kusuma, Anak Agung Ngurah Jaya and Gumilar, Khanisyah Erza and Darmawan, Ernawati and Akbar, Muhammad Ilham Aldika and Aldiansyah, Dudy and Suryawan, Aloysius and Putra, Ridwan Abdullah and Anwar, Anita Deborah and Nugraha, Laksmana Adi Krista and Andanaputra, Waskita Ekamaheswara Kasumba and Dharma, Wibisana Andika Krista and Stanojevic, Milan},
title = {Peripartum Cardiomyopathy in the Bromocriptine Era: A Systematic Review and Meta-analysis of Targeted Prolactin Blockade, Patient Selection, and Perinatal Care Pathways},
journal = {Annals of Clinical Cardiology},
year = {2026},
volume = {8},
number = {1},
pages = {4--17},
doi = {10.4103/accj.accj_22_25}
}
EUVIMED